Stock listing

Amgen Inc.

Selected listing: AMGN34 · BMFBOVESPA · BRL · BR

Amgen Inc. (B3:AMGN34), Health Technology. Latest release Sep 23, 2026: AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE…

AMGN34:BMFBOVESPABRLBRUpdated October 9, 2026

Ticker: B3:AMGN34
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: B3
Currency: BRL

About Amgen Inc.

Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.

Latest news from Amgen Inc.

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJOGREN'S DISEASE

September 23, 2026

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASE

September 22, 2026

FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®

September 14, 2026

In the PAPILLON Study, First-Line Amivantamab-Chemotherapy Demonstrates the Longest Overall Survival Reported for EGFR Exon 20 Insertion-Positive Advanced NSCLC

September 14, 2026

AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

September 9, 2026

All Amgen Inc. news →

Events

Replays

Amgen Inc. (AMGN) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Amgen Inc. (AMGN) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 04:30 PM ET
Watch
Amgen Inc. (AMGN) Q4 2025 Earnings Call
Tue, Feb 03, 2026 · 04:30 PM ET
Watch

Research Amgen Inc.

Amgen Inc. company profile

View the public company page for Amgen Inc. on 6ix.

Amgen Inc. news

Read company news and market updates connected to Amgen Inc..

Amgen Inc. investor events

Find investor webinars, events, and replay context for Amgen Inc..